Chinese equities kicked off the second quarter with a notable surge, as major indices rallied on the back of favorable policy shifts and a renewed appetite for high-tech and healthcare assets. During the morning session on April 1, the Shanghai, Shenzhen, and ChiNext indices all advanced by more than 1%, while the STAR 50 index—a barometer for China’s domestic innovation—leaped nearly 3%. This broad-based recovery reflects a market attempting to find its footing amid a complex backdrop of global geopolitical tensions and domestic regulatory adjustments.
The pharmaceutical sector emerged as a primary engine of growth, continuing a streak of outperformance that saw more than a dozen companies hit their daily price ceilings. Investors appear to be rotating into healthcare as a defensive growth play, bolstered by the maturation of domestic biotech and a steady demand for innovative medicine. Simultaneously, the 'space photovoltaics' and energy storage segments caught fire, driven by the official implementation of new energy storage policies. This regulatory milestone has funneled significant capital into renewable energy ETFs, signaling confidence in Beijing’s long-term green transition goals.
However, the rally was not universal, as traditional infrastructure and utility sectors faced headwinds. High-speed rail and power companies saw a collective pullback, suggesting a tactical shift by investors moving away from state-backed traditional industry toward high-growth technological niches. This divergence underscores a maturing market sentiment where capital is increasingly discerning, favoring sectors aligned with the 'New Quality Productive Forces' mandate frequently cited by central leadership.
External factors also played a critical role in shaping the morning’s trade. Rumors of easing tensions between Washington and Tehran provided a temporary sigh of relief for the shipping industry, which has been plagued by Middle Eastern volatility. Meanwhile, the broader tech landscape remains jittery following technical disruptions at major AI firms like DeepSeek and ongoing debates regarding the sustainability of the global AI bubble. Despite these concerns, the sheer volume of trade—surpassing 1.3 trillion yuan—indicates that liquidity remains robust as investors navigate the start of the new fiscal period.